Jason P. Rhodes, Director: Dyne Therapeutics DYN Sell · Filed 24/02/28

Trade details

Type: Insider sale
Amount: $6,653,862.74
Shares · price: 272,923 sh · $24.38 a share
Held after: 5,878,544 sh
Stock: Dyne Therapeutics DYN
Person: Jason P. RhodesDirector
Trade date: 24/02/27
Filed: 24/02/28
Days to filing: 1 days

Sold 4.4% of holdings

Share of holding sold: 4.4%

Dyne Therapeutics trades, last 26 weeks

What else happened in Dyne Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/28~24/03/28

Jason P. Rhodes's recent trades

Jason P. RhodesDirector
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$3.5M
162,954 sh
$3.5M
Filed 06/30
Traded 06/26
Jason P. RhodesDirector
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$2.2M
102,969 sh
$2.2M
Filed 06/30
Traded 06/29
Jason P. RhodesDirector
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$1.7M
81,903 sh
$1.7M
Filed 06/30
Traded 06/26
Jason P. RhodesDirector
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$1.4M
64,411 sh
$1.4M
Filed 06/30
Traded 06/26
Jason P. RhodesDirector
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$1.1M
51,756 sh
$1.1M
Filed 06/30
Traded 06/29

Jason P. Rhodes, Director — sold $6.7M of Dyne Therapeutics DYN · 4.4% of holdings · 10b5-1 plan | Whalegun